Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508555 | SCV001714780 | uncertain significance | not provided | 2019-08-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001865945 | SCV002173404 | uncertain significance | Hereditary sensory and autonomic neuropathy type 6; Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency | 2020-12-03 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with DST-related conditions. This sequence change replaces lysine with arginine at codon 1984 of the DST protein (p.Lys1984Arg). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and arginine. This variant is not present in population databases (ExAC no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |